Historical record - last NADAC effective date: 11/20/2019
Product Information
GAVISCON ES TABLET CHEW is a brand product labeled by Haleon US Holdings LLC, priced at $0.0774 per EA under NDC 00135043003. Its NADAC has been published 345 times since Nov 28, 2013.
Strength
160; 105 mg/1; mg/1
Manufacturer
Haleon US Holdings LLCNDC
00135043003
Classification
Brand
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
11/20/2019
Active Ingredients
ALUMINUM HYDROXIDE; MAGNESIUM CARBONATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M001On Market Since
6/13/2011
Price Statistics
The NADAC for GAVISCON ES TABLET CHEW has been published 345 times since Nov 28, 2013, and over the history we have for it it has risen 10.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0774 per EA |
|---|---|
| All-time high | $0.0791 (Nov 13, 2019) |
| All-time low | $0.0686 (Jan 22, 2014) |
| Median price | $0.0732 |
| Average price | $0.0741 |
| Largest weekly change | +5.8% (Apr 23, 2014) |
| Weeks tracked | 345 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+10.1%
Last surveyed Jul 1, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Haleon US Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
aluminum hydroxide and magnesium carbonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GAVISCON ES TABLET CHEW?
The current National Average Drug Acquisition Cost (NADAC) for GAVISCON ES TABLET CHEW, manufactured by Haleon US Holdings LLC, is $0.0774 per EA (NDC 00135043003), effective Jul 1, 2020.
How has the price of GAVISCON ES TABLET CHEW changed over time?
Over the history we have for it, the NADAC for GAVISCON ES TABLET CHEW has risen 10.1%. It has been tracked across 345 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GAVISCON ES TABLET CHEW?
Since Nov 28, 2013, the NADAC for GAVISCON ES TABLET CHEW has ranged from a low of $0.0686 (Jan 22, 2014) to a high of $0.0791 (Nov 13, 2019), with a median of $0.0732 per EA.
Are there cheaper alternatives to GAVISCON ES TABLET CHEW?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC HEARTBURN ANTACID CHEW TAB, is $0.0376 per EA — about 51% below GAVISCON ES TABLET CHEW.
Who manufactures GAVISCON ES TABLET CHEW?
GAVISCON ES TABLET CHEW (NDC 00135043003) is labeled by Haleon US Holdings LLC, and CMS classifies it as a brand product.